Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2024

SuperCom Ltd. (NASDAQ: SPCB) Reports Record Revenues, EBITDA and Gross Margin Growth, in Annual Fiscal Conference Call

Posted on May 2, 2024 by MissionIR

Electronic-monitoring (“EM”) security solutions developer SuperCom (NASDAQ: SPCB) has seen its revenues and gross margin grow dramatically as it serves a worldwide market for court-administered security needs and other identity technology concerns. The technology solutions company reported its Q4 and fiscal year-end … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces Fast-Anneal Feature Availability in Leap(TM) Quantum Cloud Service

Posted on May 2, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the launch of the fast-anneal feature, which is available on all D-Wave’s quantum processing units (“QPUs”) … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Q1 2024 Earnings Release, Conference Call

Posted on May 1, 2024 by MissionIR

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, today announced that it will provide a business update and release its financial results for the first quarter of 2024 following the close of the market … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Spotlighted in a Recent ‘From Lab to Launch’ Podcast Release

Posted on May 1, 2024 by MissionIR

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. Rob Etherington, President, Director and CEO … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces $4.7M Warrant Exercise Agreement

Posted on May 1, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a warrant exercise agreement with an existing accredited investor to exercise in full existing warrants. Specifically, the agreement is comprised of the purchase of 2,917,032 shares … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA

Posted on May 1, 2024 by MissionIR

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, recently announced that it has completed its three registration/validation batches of PAX-101, an IV formulation of suramin. This accomplishment marks a significant step toward submitting a New … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

Clene Inc. (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of Neurology Annual Meeting

Posted on May 1, 2024 by MissionIR

Clene (NASDAQ: CLNN), along with its subsidies, “Clene”, and its wholly owned subsidiary Clene Nanomedicine, Inc., a pioneering clinical-stage biopharmaceutical firm dedicated to enhancing mitochondrial health and safeguarding neuronal function to combat neurodegenerative disorders such as amyotrophic lateral sclerosis (“ALS”) … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment